FDA
-
-
-
-
-
-
-
Enliven Therapeutics (ELVN) PT Raised to $45 at Mizuho, 'Still an under-rated asset in the CML space'
-
-
-
-
-
-
-
Jones Trading Starts Enliven Therapeutics (ELVN) at Buy
-
-
-
-
-
-
322,995 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

